Form 4 for ABBV AbbVie
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001937048-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | ABBV | Reents Scott T | EVP, CFO | F - Tax | $232.08 | -21.6K | 38.8K | -36% | -$5.02M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2026-02-27 | F | D | 21,638 | $232.08 | 38,777 | D | — | — |